InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,358.00
(
0.19%
)
Dow Jones
42,124.65
(
0.00%
)
Brent Oil
74.87
(
1.53%
)
Bitcoin
63,604.63
(
0.44%
)
Post# of 4364
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Clootch

Send PM Follow Ignore
Followers 136
Posts 14088
Boards Moderated 0
Alias Born 09/14/2011

Clootch

Re: None

Wednesday, 01/16/2013 11:32:03 AM

Wednesday, January 16, 2013 11:32:03 AM

Post# of 4364
Sunshine Biopharma Inc. (SBFM: Quote) announced Tuesday that its parent company Advanomics Corp. has filed a new patent application for Adva-27a.


Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant breast cancer cells as well as other aggressive cancer cells in vitro. The compound is currently in the IND-Enabling stage of development.

20 Day Moving Average vs Price Buy
20 - 50 Day MACD Oscillator Buy

52Wk Low 0.1410
Since 01/30/12 (+169.50%)

New Board for anyone to Post responsible plays

http://investorshub.advfn.com/boards/board.aspx?board_id=22648

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up